We present image findings, especially rare MRI of a primary breast angiosarcoma with its histopathology, and also analyze the relevant medical literature reports in terms of the MRI findings. As our patient had unique features of a primary breast angiosarcoma, this case could be very helpful for future diagnosis of this rare breast malignancy by MRI.
INTRODUCTION
Primary breast angiosarcoma (PBA) is a very rare breast malignancy with a poorer prognosis than that of the usual ductal carcinoma. There have already been published studies and case reports regarding the clinical behavior and pathologic appearance of PBA. However, in those manuscripts it is difficult to find a description of breast MRI that has an important role in the differential diagnosis in clinical practice. Furthermore, the number of studies with appropriate T1, T2, and dynamic contrast enhancement (DCE) sequences using dedicated breast MRI, i.e. the basis of current breast MRI analysis, is very small and the results are quite variable (1) (2) (3) (4) . Therefore, a larger number of radiology reports will be required in order to diagnose PBA using breast MRI. We present a case of PBA we experienced along with a set of helpful MRI findings. We also attempted to help diagnose this rare clinical entity using breast MRI by summarizing the articles that have been published to date.
CASE REPORT
A 50-year-old woman with no previous medical history presented with a diffuse enlargement of the left breast which she had already noticed for four months. On physical examination, the left breast was seen to be swollen but without skin changes or sign of inflammation. There was also no apparent axillary lymphadenopathy. Mammography demonstrated an extremely dense breast without a definite mass or microcalcifications. Sonography revealed irregular indistinct heterogeneous echoic mass of the upper inner quadrant of the breast and demonstrated increased vascularity in the hypoechoic portion (Fig. 1) . The patient underwent a core biopsy with a 14-gauge This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
needle and pathology suggested angiosarcoma of the breast. MRI revealed a 4.9 × 4.5 cm, irregularly shaped, low signal mass on T1-weighted imaging (T1WI). Several, dot-like, high signals, suggesting internal hemorrhagic foci within the mass, were noted. The mass showed high signal intensity on T2WI. The central portion of the mass showed early dynamic contrast enhancement (DCE) and a washout pattern (Type III). The periphery of the mass showed persistent trapping of contrast medium as irregularly margined enhancing portion (Type I) as well as the surrounding edema. Large, draining vessels around the mass were very visible on maximum intensity projection (MIP) imaging. Positron emission tomography computed tomography (PET-CT) showed inhomogeneous fluorodeoxyglucose (FDG) uptake with a 2.2-2.9 standardized uptake value (SUV) of the mass without an extra-mammary lesion (Fig. 2) . Core needle biopsy of the left breast revealed a combination of the numerous, inter-anastomosing vascular spaces and more solid, spindle-cell areas effacing the normal lobular architecture. On immunohistochemistry, tumor cells are diffusely and strongly positive for CD34 and focally positive for factor VIII. The estimated Ki-67 index in cellular areas is approximately 40% (Fig. 3) . Modified radical mastectomy was performed and the final diagnosis of this patient was intermediate-grade PBA. Following modified radical mastectomy, the patient underwent two cycles of AC (Doxorubicin/Cyclophosphamide) and 12 cycles of Taxol adjuvant chemotherapy and received adjuvant radiotherapy. However, the patient expired after subsequent skin, liver, and spleen metastases developed.
DISCUSSION
Breast sarcomas are a heterogeneous group of malignancy arising from the mammary stroma, and angiosarcoma is the most common sarcoma of the breast. PBA is regarded as a vascular malignancy arising within breast parenchyma with or without minimal extension into overlying skin. It is a very rare, accounting for only 0.04% of all malignancy of breast.
PBA often occurs in young and fertile women between 20 and 50 years of age and who are younger than those with ductal cancer and below the recommended age for mammographic screening. Discoloration of the overlying skin is the most typical sign of PBA, although this only occurs in 17% of all diagnosed cases (5). The PBA may have an insidious clinical onset, presenting as a painless, discrete, palpable mass that grows rapidly. Patients may complain of a painful mass with tenderness. Approximately 2% of patients present with diffuse enlargement of the breast and a bluish discoloration of the skin (6). Generally, discharge and retraction of nipple or axillary node involvement are absent. Some patients are diagnosed during pregnancy or shortly after delivery (7); it is believed that there is a hormonal effect on the development of this disease. However, there are several cases of bilateral tumors diagnosed in postmenopausal period (8) .
On mammography, PBA appears as a not circumscribed mass and lacking the spiculations usually seen in ductal origin breast cancer. Rarely, the tumor may show a soap bubble appearance. They rarely manifest coarse, nonbranching microcalcifications (8) . PBA could be seen as having focal asymmetry, an oval or lobular mass feature, and rarely there may be skin thickening (1) . In many cases of some case reports, PBA was not detected on mammography as in our case. The authors explained the dense breast parenchyma, characteristic of young women could obscure PBAs (1-2, 9) .
Sonography usually shows a solid mass that may have well-defined or lobulated margins and with either hypoechoic or hyperechoic appearance. There is often no posterior shadowing (8) . PBA can be seen as a complex mass with both cystic and solid regions (10) which can show adjacent tubular structures consistent with vessels (9). Irregular, spiculated hypoechoic masses, overlying skin thickening, and diffuse edematous change also can be seen In clinical practice, when a breast lesion is detected, MRI is the best imaging modality for its characterization. We searched for a published study regarding the MRI findings of PBA. Since Liberman et al. (9) first described the MRI findings for PBA, 10 published articles have shown MRI findings for PBA (Table 1) . Based on these articles, most PBAs show irregular shape, poorly defined margin heterogeneous echoic mass with architectural distortion. T1WI shows a low signal, and in areas with a hemorrhagic nature or intratumoral hematoma, T1WI may show a high-signal-intensity focus. T2WI usually has high signal intensity. Slow flowing blood in a large anastomotic vascular space seems to cause high signal intensity in T2WI. When this structure forms a venous lake, it shows a cystic cavity. The kinetic study is shown in seven out of 10 studies in which a total of 21 patients with PBAs were enrolled. The most frequent type (12) I pattern was in 11 patients, followed by eight patients with the type III pattern and two patients with the type II pattern. The Type I pattern can be defined as trapping of the contrast medium within the anastomotic vascular space. Other findings may include showing a large draining vessel around the tumor (Table 1) .
Architectural and kinetic features are valuable for interpreting breast MRI. The specificity of breast MRI could be enhanced by adding information from the DCE study to the architectural features of a lesion. Therefore, assessment *Articles with proper T1, T2, and dynamic contrast enhancement sequences. ADC = apparent diffusion coefficient; DWI = diffusion-weighted imaging; MIP = maximum intensity projection; N/A = not available; preop. = preoperative; SI = signal intensity; STIR = short-T1 inversion recovery of all breast lesions should depend not only on architectural but also on kinetic criteria. In this context it can be said that an appropriate evaluation of PBA was made in only four out of 10 studies (1-4). Among them, only five out of 21 cases were presented with figures that can be referenced for the actual radiological diagnosis. Therefore, there has been a total of 10 articles that have described MRI of PBA, however, as there are limitations to referencing them, our case presentation, including our proper MRI setting, is important.
Our case has all of the characteristic MRI findings of PBA presented earlier, although it differs from the previously introduced cases in that the central and the periphery of the mass have different kinetic curves.
PET-CT is useful for confirming preoperative axillary involvement and distant metastasis.
The prognosis of the PBA is similar to other histopathology type of sarcoma and is related to the tumor size, grade, and the status of resection margin (13) . Surgical removal followed by adjuvant chemotherapy seems to improve the patient prognosis (7). However, the overall prognosis is poor compared to that of mammary carcinoma. Total mastectomy is mandatory because the PBA often invades microscopically beyond its gross limits, and axillary lymph node dissection is not necessary since nodal metastasis is rare.
In summary, mammography and sonography findings of PBA are indistinguishable from those of other breast malignancies. However, this rare malignancy is distinguished from other malignancies by several characteristic MRI findings, i.e. T2WI high signal intensity, hemorrhage foci at T1WI, and a kinetic curve which could be interpreted as a benign tumor. The center and periphery of the mass could show different DCE kinetics, as was the case in our patient. Draining vein is also a feature of the tumor periphery. A PBA should be included in the differential diagnosis in breast tumors with the MRI findings listed above.
